When was Emcure founded?

Emcure was founded in 1981 and raised its 1st funding round 25 years after it was founded.

Where is Emcure located?

Emcure is headquartered in Pune, India. It is registered at Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Infotech Park (Hinjawadi), Pune, Pune City, Maharashtra, India, 411057.

Who is the current CEO of Emcure?

Satish Ramanlal Mehta of Emcure. They have also founded 1 company and are angel investors in 3 startups.

Which legal entities is Emcure associated with?

Emcure is associated with EMCURE PHARMACEUTICALS LIMITED and 5 others.

How many employees does Emcure have?

As of Mar 31, 2025, the latest employee count at Emcure is 6731.

Is Emcure a funded company?

Emcure is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Jul 10, 2006.

When was the latest funding round of Emcure?

Emcure's latest funding was a $***** PE round on Jul 10, 2006, with participation from 1 investor.

What is the annual revenue of Emcure?

Annual revenue of Emcure is more than ₹1,000 Cr as on Mar 31, 2026

Where does Emcure rank among its competitors?

Emcure ranks 5th amongst 198 active competitors, of which 13 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Dr. Reddy's Laboratories, which secured ₹30Cr in Feb, 2025.

Who are the top competitors of Emcure?

Emcure's top competitors include Bayer, Wockhardt and Biological E. Among them, Dr. Reddy's Laboratories secured the most recent funding round in February, 2025.

Emcure - 2026 Company Profile, Team, Funding, Competitors & Financials

Emcure is a public company based in Pune (India), founded in 1981 by Satish Ramanlal Mehta. It operates as a Developer, manufacturer, and markets a broad range of pharmaceutical products. Emcure has raised $50M in funding from Blackstone. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Biological E.

Company Details

Developer, manufacturer, and markets a broad range of pharmaceutical products. It offers a range of pharmaceutical products across various therapeutic areas, including gynecology, cardiology, oncology, blood disorders, HIV, respiratory, CNS, and anti-infectives. It also produces formulations, biologics, and active pharmaceutical ingredients.

Website: www.emcure.com
Social
Email ID: *****@emcure.com
Phone Number: +91 **********
Registered Address: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Infotech Park (Hinjawadi), Pune, Pune City, Maharashtra, India, 411057

Key Metrics

Founded Year

1981

Location

Pune, India

Stage

Public

Total Funding

$50M in 1 round

Latest Funding Round

PE, Jul 10, 2006, $*****

Investors

Blackstone & 1 more

Ranked

5^th among 198 active competitors

Annual Revenue

₹1,000+ Cr as on Mar 31, 2026

Employee Count

6,731 as on Mar 31, 2025

Investment & Acquisitions

Zuventus & 6 more

Similar Companies

Bayer & 211 more

Exit Details

Public

View Emcure's full profile

Emcure is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Emcure Pharmaceuticals Limited CIN: 13.149.269/0001-86 , Brazil, Active	Jan 24, 2011	-	6344 (As on Mar 31, 2025)	-
TILLOMED LABORATORIES LIMITED CIN: 2544103 , United Kingdom, Active	Sep 27, 1990	-	51 (As on Mar 31, 2024)
AVET LIFESCIENCES PRIVATE LIMITED CIN: U24299PN2020PTC193397 , India, Active	Aug 26, 2020	₹1,000+ Cr (As on Mar 31, 2025)	51 (As on Apr 01, 2026)
ZUVENTUS HEALTHCARE LIMITED CIN: U85320PN2002PLC018324 , India, Active	May 27, 2002	₹1,000+ Cr (As on Mar 31, 2026)	3281 (As on Apr 01, 2026)
EMCURE PHARMACEUTICALS LIMITED CIN: L24231PN1981PLC024251 , India, Active	Apr 16, 1981	₹1,000+ Cr (As on Mar 31, 2026)	7124 (As on Apr 01, 2026)
GENNOVA BIOPHARMACEUTICALS LIMITED CIN: U24231PN2001PLC016253 , India, Active	Jun 19, 2001	₹100 - ₹500 Cr (As on Mar 31, 2025)	897 (As on Apr 01, 2026)

Emcure got listed on Jul 10, 2024.

Click here to take a look at Emcure's IPO in detail

Emcure has raised a total funding of $50M over 1 round. Its latest funding round was a PE round on Jul 10, 2006 for $*****. 1 investor participated in its latest round. Emcure has 2 institutional investors.

Here is the list of recent funding rounds of Emcure:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 10, 2006	1966049	PE	6456852	3227849	1435490	1881236

Access funding benchmarks and valuations. Sign up today!

View details of Emcure's funding rounds and investors

The founders of Emcure is Satish Ramanlal Mehta. Satish Ramanlal Mehta is the CEO of Emcure.

Here are the details of Emcure's key team members:

Satish Ramanlal Mehta: Founder, CEO & MD of Emcure. They are also an angel investor in 3 startups and serve on the board of 1 company.
Contact Info: 1 email address

Emcure's Board of Directors

Emcure's board has 5 active members. Satish Ramanlal Mehta is part of team and Namita Vikas Thapar, Vidya Yeravdekar, Berjis Minoo Desai and Samit Satish Mehta are independent board members.

Here is the list of Emcure's board of directors:

Name	Type	Representing	Status	Duration
Satish Ramanlal Mehta	Team	-	Current	45y 6m
Namita Vikas Thapar	Independent board member	-	Current	12y 3m
doommpl	Independent board member	-	Current	5y 9m
gdybzwp	Independent board member	-	Current	1y 7m
mxdpsqh	Independent board member	-	Current	4y 6m
urzvmdr	Independent board member	-	Past	9y 9m
ogasudl	Independent board member	-	Past	8y 6m
jsokcsc	Independent board member	-	Past	1y 1m
prfwylr	Independent board member	-	Past	6y 5m
dxtlijc	Independent board member	-	Past	6y 6m

View details of Emcure's Founder profiles and Board Members

Emcure's employee count trend

Emcure has 6,731 employees as of Mar 25. Here is Emcure's employee count trend over the years:

Uncover Emcure's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Emcure include Bayer, Wockhardt and Biological E. Here is the list of Top 10 competitors of Emcure, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
3rd	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
4th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
5th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Bain Capital, Blackstone	68/100
6th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
7th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
8th	Lupin 1968, Mumbai (India), Public	Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients	-	Cipher International, AbbVie & 5 others	67/100
9th	Aurobindo Pharma 1986, Hyderabad (India), Public	Provider of generic biocatalytic products	-	Affirma Capital, India Capital Growth & 4 others	66/100
10th	Dr. Reddy's Laboratories 1984, Hyderabad (India), Public	Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health	-	Life Insurance Corporation of India, Gates ... & 4 others	65/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Emcure's competitors? Click here to see the top ones

Founders own 25.17%, Funds own 13.18%, Other People (largest shareholder) own 52.07% and Other Investors own 9.48%. The net worth of Emcure's founders is INR 430Cr as of Aug 03, 2006. The cap table displayed below is for EMCURE PHARMACEUTICALS LIMITED which is the legal entity associated with Emcure.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	25.17%	430Cr	6939518	8912380	3107543	3712317
Satish Ramanlal Mehta	4872745	3915310	8215867	4118731	4606831	2165448
Fund	13.18%	225Cr	1164190	5807703	8241592	9239670
Blackstone	5341401	4696669	8365960	9709834	7754703	4000839
Other People	52.07%	889Cr	7114482	2621059	2632322	6875835
Other Investors	9.48%	162Cr	4754445	9585489	7717945	6516590
Total	99.90%	1,710Cr	6875516	1252548	8101602	3415957

Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.

Disclaimer

Emcure has made 1 investments in companies including Torrent Urja 47. Emcure has also acquired 6 companies including Zuventus and Bhardwaj.

Here is the list of investments & acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jun 21, 2025	Acquisition	Zuventus	2002	Mumbai (India)
Jun 02, 2025	Investments	Torrent Urja 47		-
Jan 18, 2016	Acquisition	Marcan Pharmaceuticals	2005	Ottawa (Canada)